Cetrorelix Acetate Injection shortage

To Be Discontinued

Cetrorelix Acetate Injection is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.

Therapeutic category

Reproductive

Dosage form

Injection

Routes

SUBCUTANEOUS

Last updated

11/13/2025

Strength variants

Not specified

Need sourcing help for Cetrorelix Acetate Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Teva Pharmaceuticals USA, Inc.800-545-8800
To Be Discontinued

Reason for shortage

Not specified

ad slot 300x250

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.